The ever-expanding popularity of GLP-1 drugs for weight loss is challenging employers to balance access and cost.

Since their introduction, GLP-1 medications have rapidly gained popularity for their effectiveness in helping people manage ...

They’ve been billed as “miracle drugs,” promising weight loss, improved heart health, and better blood sugar control. But as ...

The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of ...

Surging demand for Ozempic and other GLP-1 drugs is adding up for some Minnesota employers. Why it matters: The popular ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

The World Health Organization issued new guidance this week on the use of popular GLP-1 drugs, like Ozempic, Wegovy, Mounjaro ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

In matched cohorts of more than 41,000 patients each, use of tirzepatide was linked to a significantly reduced risk of ...

Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...

Okava Pharmaceuticals, a San Francisco based company, plans to introduce on Tuesday a new GLP-1 clinical weight loss study for cats. MEOW-1, as the study is called, will look to use OKV-119, a ...